NCT04404192Phase 2Completed

PH94B in the Treatment of Adjustment Disorder With Anxiety

Study sponsor: VistaGen Therapeutics, Inc. · VTGN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-12-14Actual
Enrollment · participants41Actual
Source updated2026-02-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Hamilton Anxiety Scale. After: Measure: Hamilton Anxiety Scale (HAM-A) Score.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview